$2M in Federal Funding for PILLAR’s Project Re-entry and Treatment Network

Translate to Spanish or other 102 languages!

Senator Henry Cuellar announced $2,000,000 in federal funding for PILLAR's Project Re-entry and Treatment Network. Courtesy Image
Senator Henry Cuellar announced $2,000,000 in federal funding for PILLAR’s Project Re-entry and Treatment Network. Courtesy Image

Mega Doctor News

- Advertisement -

Senator Henry Cuellar announced $2,000,000 in federal funding for PILLAR’s Project Re-entry and Treatment Network. The funds, awarded by the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA), will be used to provide re-entry services, treatment, and recovery support services for 330 individuals.

PILLAR will utilize the award over a 5-year period to treat incarcerated individuals struggling with substance use disorders and/or co-occurring disorders as they return to their families and community. 50 persons will be treated in Year 1, and 70 persons will be treated each year in Years 2 through 5.

Mental health care is essential to our community’s wellbeing. This $2,000,000 investment will help PILLAR provide the care and treatment needed to get individuals suffering with substance use disorders back on their feet and back into the world. The senator woud like to thank PILLAR Co-Founders Arturo Diaz, Jr., and Manuel Sanchez for working with him to deliver for the community.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

Coordinated Care Supports Mother through Cancer and Pregnancy

Mega Doctor News By Kristen Zapata | UT Health San Antonio Two pink...
- Advertisement -